Separately, India plans to begin its first ever national survey during the next few months to determine the rate of multi-drug-resistance nationwide, according to Prahlad Kumar, director of the National Tuberculosis Institute, a government research and training center in Bangalore.

WSJ: Tuberculosis Strain in Mumbai Doesn't Respond to Main Treatment